Navigation Links
Covance Elects John McCartney to Company's Board of Directors
Date:5/7/2009

PRINCETON, N.J., May 7 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) announced that it has elected John McCartney to its board of directors.

Mr. McCartney currently serves as chairman of the board of A.M. Castle Corporation, a provider of specialty products, services, and supply chain solutions. He was formerly president and chief operating officer of U.S. Robotics (USR), a multibillion dollar provider of information access technologies. He was a senior executive in the management team that grew USR from $7 million to $2 billion in revenue. Mr. McCartney also served on the board of USR for 12 years. He joined USR in 1984 as vice president and chief financial officer.

"We are very pleased to welcome Mr. McCartney to our board of directors. His accomplishments and more than 20 years of experience in general management, finance, and information technology services will strengthen Covance's strategy to provide high-quality drug development data to our clients worldwide and build a scalable management structure," said Joe Herring, Covance chairman and CEO.

"I am honored to be part of such an accomplished group of individuals," said Mr. McCartney. "I am looking forward to leveraging my experience to enhance Covance's ability to deliver integrated service solutions to its clients as well as drive value to its shareholders."

Mr. McCartney is currently a member of the board of directors of Huron Consulting Group, Incorporated, Federal Signal Corporation, and Datatec, Limited. He is also a member of the boards of Lycee Francais of Chicago, St. Ignatius College Prep, and the Graduate Advisory Board of the Wharton School of Business at the University of Pennsylvania.

Mr. McCartney graduated with a bachelor's degree in philosophy from Davidson College and earned his master's degree in business administration from the University of Pennsylvania's Wharton School of Business.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.7 billion, global operations in more than 25 countries, and more than 9,800 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.


'/>"/>
SOURCE Covance Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets
2. Covance Opens New Clinical Development Offices in Chile, Peru and Expands Argentina Office
3. Jina Ventures Advises Swiss Pharma Contract on Strategic Sale to Covance Inc
4. Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site
5. Covance Purchases Equity Stake in Caprion Proteomics
6. Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
7. Covance Decides to Pursue Its Original Preclinical Strategy in China
8. Covance and WuXi PharmaTech to Form a Joint Venture to Provide World-Class Preclinical Services in China
9. Covance to Present at The R.W. Baird 2008 Growth Stock Conference
10. Covance to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
11. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... WARSAW, Ind. , May 23, 2016 Zimmer ... in musculoskeletal healthcare, today announced that its Board of Directors ... stockholders for the second quarter of 2016. ... on or about July 29, 2016 to stockholders of record ... Future declarations of dividends are subject to approval of the ...
(Date:5/23/2016)... ... 23, 2016 , ... Foresight Institute , a leading ... for the 2015 Foresight Institute Feynman Prizes. , These prestigious prizes, named ... for experiment and the other for theory in nanotechnology. Prof. Markus J. Buehler, ...
(Date:5/20/2016)... ... 20, 2016 , ... Korean researchers say Manumycin A triggers apoptosis, or natural ... to treat the disease. Surviving Mesothelioma has just posted an article on the new ... institutions based their mesothelioma study on the fact the Manumycin A, a derivative of ...
(Date:5/19/2016)... , May 19, 2016 There ... fully recover given the relentless pressures in pricing and ... in the investors circle though - numerous opportunities are ... of today,s session, ActiveWallSt.com,s presents four names in this ... Vitae Pharmaceuticals Inc. (NASDAQ: VTAE ), Anthera ...
Breaking Biology Technology:
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
(Date:3/21/2016)... , March 22, 2016 ... with passcodes for superior security   ... leading provider of secure digital communications services, today announced ... technology and offer enterprise customers, particularly those in the ... recognition and voice authentication within a mobile app, alongside, ...
(Date:3/15/2016)... --> --> ... Research "Digital Door Lock Systems Market - Global Industry Analysis, ... global digital door lock systems market in terms of revenue ... forecast to grow at a CAGR of 31.8% during the ... enterprises (MSMEs) across the world and high industrial activity driving ...
Breaking Biology News(10 mins):